Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: Role of apoptosis

This publication has 17 references indexed in Scilit:

• Specific low affinity binding sites for gonadotropin-releasing hormone in human endometrial carcinomata
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1991
• Effect of combination treatment with analogs of luteinizing hormone-releasing hormone (LH-RH) or somatostatin and 5-fluorouracil on pancreatic cancer in hamsters
  International Journal of Cancer, 1991
• Histological changes in dunning prostate tumors and testes of rats treated with LH‐RH antagonist SB‐75
  The Prostate, 1991
• Grwoth Inhibition of Mouse MXT Mammary Tumor by the Luteinizing Hormone-Releasing Hormone Antagonist SB-75
  JNCI Journal of the National Cancer Institute, 1990
• Membrane Receptors for Peptides in Experimental and Human Pancreatic Cancers
  Pancreas, 1989
• Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone.
  Proceedings of the National Academy of Sciences, 1989
• Receptors for luteinizing hormone‐releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia
  The Prostate, 1989
• Roles of antiestrogen binding sites in human endometrial cancer cells
  Journal of Steroid Biochemistry, 1987
• Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist
  Nature, 1985
• Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.
  Proceedings of the National Academy of Sciences, 1982